🎆2026 https://t.co/5xo7LSIrN4 New Year Airdrop🎉
Snag your slice of 10,000 $ANB rewards by finishing a few quick tasks:
🔶Connect your X account and follow @ant_fun_trade
🔶Retweet our post
🔶Make your first trade on Web (0 fees!) or in the App
🔶Invite friends and earn extra bonuses
Event ends in 15 days, check the details on the event page.
Join now: https://t.co/YgHTiUmKnk
Fully Local Wallet Control + Multi-Chain All-in-One + Zero Platform Fee = Your Future Trading!
Thank you once again to all our attendees for making the ENSCCA/Precision-BTC-Network Joint Meeting an unforgettable event! Your energy and contributions made it truly special. Thank you Krakow for hosting us! 🇵🇱 Looking forward to our next gathering! #ENSCCA#PrecisionBTCNet
Next, Dr. Rita Balsano from the Humanitas Research Hospital discusses the immune and molecular profiling of BTC patients undergoing chemo-immunotherapy. #PrecisionBTCNet#ENSCCA#Krakow2024 🔬🇵🇱
#LiverTwitter, exciting news! 🎉 My abstract has been accepted for #EASLCongress 2024 in Milan, Italy, from June 5-8. I hope to see you there – secure your spot now and let's revolutionise liver science together! 💡👩🔬 https://t.co/F3900WySH0 @EASLNews
🔥Recent advances in systemic therapy for advanced intrahepatic cholangiocarcinoma
👏Comprehensive & detailed update on 💊options for CCC > IO & 🎯therapies by @changhoon_yoo & colleagues
👇https://t.co/yC1W2Kie8e in Liver Cancer
@myESMO@EASLedu@OncoAlert@ILCAnews
NORPACT-1 trial #ASCO23
❓Neoadyuvant mFOLFIRINOX for RESECTABLE #PDAC
🏴☠️4 cycles before surgery (8 after)
🔪82% (89% if surgery upfront) underwent resection
❌No improvement on OS / R0 resection in ITT population
👉CONCLUSION: Upfront surgery for RESECTABLE PDAC
@OncoAlert
🔥Hot off the Press
Pancreatic Ductal #Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of #Immunotherapy and Spikes of Lights
by Rita Balsano, Valentina Zanuso et al
👉https://t.co/sKtSThbEza
🔥Association of Antibiotic With Survival Among Patients With #PDAC Receiving Chemotherapy
@JAMANetworkOpen
https://t.co/13N0i7rAGX
🔎🇺🇸3850 pts -> 2178 with antibiotics
👉⬆️ OS among pts treated with gemcitabine, but not 5-Fu
🤔And now? Enough RWE for prospective trial?
@myESMO
🔥Comparison of genomic profiling of ctDNA in pancreaticobiliary malignancies in plasma & bile
@JournalCancer
https://t.co/V1oErPVkug
🔎🇯🇵RWD 83 pts
👉 bile: GA in 55%
👉🩸: GA in 24%
👉Overall: 23/83 with 💊🎯
🧐no tissue? Get bile and/or🩸 !
@myESMO@EASLedu#livertwitter
#GoircAcademy has been one of the most exciting job experience I have done. High experienced clínician scientists worked side by side with young oncologists for 2 days to write their clínical trial proposal. Can’t wait 4 next edition! @ChiaraTommasi7@a_musolino
This is Mjriam Capula with the research team she is working with 🙂
She is the winner of the Short-term Scientific Stay Award 2022 promoted by PCE.
@VUamsterdam is the university she has chosen to carry out her project.
💜 Enjoy your time abroad, Mjriam!